International Business Settlement Holdings has agreed to acquire QuantumCompute Solutions for HK$563 million, a proposed deal that would give the company an indirect stake in an AI chip designer. The IBS acquisition had not been completed when it was announced on October 30, 2026.

Key Takeaways

  • IBS agreed to buy all of QuantumCompute Solutions from its shareholder.
  • QuantumCompute indirectly owns about 85.94% of Shanghai Tianjing Fulian.
  • The announcement did not specify a completion date or transaction conditions.

IBS acquisition structure

IBS, whose shares trade in Hong Kong under stock code 0147, entered into a share purchase agreement for QuantumCompute’s entire equity interest. If the deal completes, QuantumCompute will become a wholly owned IBS subsidiary and its results will be consolidated into the group’s financial statements.

QuantumCompute’s indirect holding in Shanghai Tianjing Fulian is approximately 85.94%. Foxconn Industrial Internet, which is listed in Shanghai, owns a separate 5.56% stake in the chip business.

The announcement did not disclose how the HK$563 million consideration would be paid, the conditions to completion or an expected closing date.

AI chip design and edge computing

Shanghai Tianjing Fulian designs and develops AI system-on-chip products and integrated solutions, focusing on low-power, cost-effective AI and edge computing applications. IBS said the business is an authorised independent chip design house for MediaTek.

MediaTek’s explanation of edge AI describes processing AI features on devices rather than relying solely on cloud-connected support. That provides context for the target’s focus, though it does not verify the transaction or its products.

IBS’s directors said the deal would expand the group beyond its existing fintech and computing-power services into AI chip design and edge computing infrastructure. They expect the acquisition to accelerate that entry compared with developing the capabilities internally.

Strategic consultant appointed

IBS also appointed Dr. Tang Tianshen as chief strategic consultant to advise on the development and operations of its fintech-related businesses. The company said Tang previously held senior roles at Intel, Shanghai Hua Hong and SMIC.

Read More News

More FinanceVelix news

Disclaimer

This FinanceVelix article provides general information, not personalized financial, investment, legal, or tax advice. Market prices, interest rates and economic conditions can change; investments carry a risk of loss. Facts reflect the material available when published and may change. Check important information independently and consult a qualified professional when needed. Mentioning an asset, company, or service is not an endorsement.